November 15, 2023
9:00am – 10:00am
Venue
NRB 132 / Zoom
“Improving the Efficacy and Durability of Gene Editing Therapies for Duchenne Muscular Dystrophy””
Melissa Spencer, Ph.D.
Professor and Neuromuscular Program Director
Co-Director, Center for Duchenne Muscular Dystrophy at UCLA Health
David Geffen School of Medicine at UCLA
Hybrid Event
In-Person: NRB 132 (Auditorium)
Virtual: Zoom Webinar (Passcode: 123456)
For more information, please contact Oscar Arellano at OArellano@mednet.ucla.edu.